VIVO Historical Earnings image   This VIVO historical earnings page last updated 5/24/2022
VIVO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20225/6/20220.11B
Q1 20222/4/20220.09B
Q4 202111/12/20210.08B
Q3 20218/6/20210.06B
Q2 20215/7/20210.09B
Q1 20212/5/20210.09B
Q4 202011/13/20200.06B
Q3 20208/7/20200.08B
Q2 20205/8/20200.06B
Q1 20202/7/20200.05B
Q4 201911/7/20190.05B
Q3 20197/30/20190.05B
Q2 20194/30/20190.05B
Q1 20191/24/201951.48M
Q4 201811/8/201853.10M
Q3 20187/31/201851.74M
Q2 20184/26/201856.45M
Q1 20181/25/201852.28M
Q4 201711/9/201749.70M
Q3 20177/27/201750.14M
Q2 20174/27/201754.12M
Q1 20171/25/201746.81M
Q4 201611/10/201647.07M
Q3 20167/28/201650.66M
Q2 20164/28/201651.26M
Q1 20161/27/201647.16M
Q4 201511/5/201547.07M
Q3 20157/23/201548.20M
Q2 20154/23/201551.55M
Q1 20151/22/201548.01M
Q4 201411/6/201446.69M
Q3 20147/24/201447.20M
Q2 20144/24/201450.10M
Q1 20141/22/201444.80M
Q4 201311/7/201349.00M
Q3 20137/25/201347.10M
Q2 20134/25/201347.30M
Q1 20131/23/201345.40M
Q4 201211/8/201243.70M
VIVO Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20225/6/20220.660
Q1 20222/4/20220.350
Q4 202111/12/20210.230
Q3 20218/6/20210.220
Q2 20215/7/20210.560
Q1 20212/5/20210.650
Q4 202011/13/20200.190
Q3 20208/7/20200.550
Q2 20205/8/20200.230
Q1 20202/7/20200.100
Q4 201911/7/20190.130
Q3 20197/30/20190.160
Q2 20194/30/20190.190
Q1 20191/24/20190.2
Q4 201811/8/20180.2
Q3 20187/31/20180.18
Q2 20184/26/20180.21
Q1 20181/25/20180.15
Q4 201711/9/20170.15
Q3 20177/27/20170.16
Q2 20174/27/20170.22
Q1 20171/25/20170.15
Q4 201611/10/20160.14
Q3 20167/28/20160.21
Q2 20164/28/20160.24
Q1 20161/27/20160.21
Q4 201511/5/20150.2
Q3 20157/23/20150.22
Q2 20154/23/20150.24
Q1 20151/22/20150.19
Q4 201411/6/20140.2
Q3 20147/24/20140.21
Q2 20144/24/20140.24
Q1 20141/22/20140.18
Q4 201311/7/20130.22
Q3 20137/25/20130.24
Q2 20134/25/20130.24
Q1 20131/23/20130.2
Q4 201211/8/20120.21
Quotes delayed 20 minutes

Email EnvelopeFree VIVO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Meridian Bioscience (VIVO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VKTX Past Earnings
VLON Past Earnings
VNDA Past Earnings
VOR Past Earnings
VRAY Past Earnings
VRCA Past Earnings
VRDN Past Earnings
VRPX Past Earnings
VRTX Past Earnings
VSTM Past Earnings
What was the record high VIVO historical earnings result?
In terms of earnings or revenue, what is the best VIVO historical earnings result that Meridian Bioscience has ever posted, and when?

✔️Accepted answer: Within our data set, the highest VIVO historical earnings result was set in Q2 2022, when Meridian Bioscience posted results of 0.660/share. The most successful revenue quarter within our data set was Q2 2022 when Meridian Bioscience reported revenue of 0.11B.

What was the lowest Meridian Bioscience historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest VIVO has reported, and when?

✔️Accepted answer: Within our data set, the lowest VIVO historical earnings result was set in Q1 2020, when Meridian Bioscience posted results of 0.100/share. The smallest revenue quarter within our data set was Q4 2012 when Meridian Bioscience reported revenue of 43.70M.

On this page we presented the VIVO historical earnings date information for Meridian Bioscience. Reviewing that VIVO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2022, when VIVO posted adjusted EPS of 0.660/share. Meanwhile the lowest VIVO historical earnings result was in Q1 2020, when VIVO posted adjusted EPS of 0.100/share. Moving to Meridian Biosciences historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when VIVO reported 0.11B in revenue, while the smallest revenue quarter was Q4 2012 when VIVO reported 43.70M in revenue.

For self directed investors doing their due diligence on VIVO or any other given stock, their research can benefit from looking into all of the Meridian Bioscience historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Meridian Bioscience historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for VIVO. Thanks for visiting, and the next time you need to research VIVO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: GLMD Options Chain, Top Ten Hedge Funds Holding FUMB, Top Ten Hedge Funds Holding TLOG.

 

VIVO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.